| Literature DB >> 27923356 |
Paola Bully1, Alvaro Sanchez2, Gonzalo Grandes2, Haizea Pombo2, Ma Soledad Arietalenizbeaskoa2, Veronica Arce2, Catalina Martinez2.
Abstract
BACKGROUND: Feasible and valid assessment of healthy behaviors is the first step for integrating health promotion in routine primary care. Therefore, the aim of this study was to develop and evaluate the validity and reliability of the "prescribe healthy life" screening questionnaire, a brief tool for detecting physical activity levels, consumption of fruit and vegetables, tobacco use and patients' compliance with minimal recommendations.Entities:
Keywords: Lifestyle; Mass screening; Primary health care; Risk reduction behavior; Sensitivity and specificity; Validation studies
Mesh:
Year: 2016 PMID: 27923356 PMCID: PMC5142282 DOI: 10.1186/s12889-016-3898-8
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Timeline of measurement and data collection
Sociodemographic and clinical characteristics of patients
| Number | Percent | |
|---|---|---|
| Age | ||
| 10–19 years | 7 | 5.56 |
| 20–29 years | 20 | 15.87 |
| 30–39 years | 29 | 23.02 |
| 40–49 years | 38 | 30.16 |
| 50–59 years | 19 | 15.08 |
| 60–65 years | 13 | 10.33 |
| Level of studies | ||
| no studies | 2 | 1.59 |
| Primary studies | 18 | 14.29 |
| Elementary post-secondary education, secondary school graduate, basic general education up to year 8 | 24 | 19.05 |
| Secondary education, professional training, advanced secondary education | 22 | 17.46 |
| 2nd Degree Professional training, Advanced Level Training Cycle | 19 | 15.08 |
| Diplomas | 7 | 5.56 |
| Graduate degrees, higher technicians | 34 | 26.98 |
| Main situation | ||
| Active worker | 65 | 51.59 |
| Unemployed having worked previously | 16 | 12.70 |
| Seeking first job | 5 | 3.97 |
| Retired, pensioner or independently wealthy | 6 | 4.76 |
| Studying | 15 | 11.90 |
| Houseworker | 10 | 7.94 |
| Disabled | 7 | 5.56 |
| Other situations | 2 | 1.59 |
| Cancer | ||
| No | 124 | 100.00 |
| Cardiovascular Pathologies | ||
| No | 110 | 88.71 |
| Yes | 14 | 11.29 |
| Mental Disorders | ||
| No | 113 | 91.13 |
| Yes | 11 | 8.87 |
| Musculoskeletal Pathologies | ||
| No | 116 | 93.55 |
| Yes | 8 | 6.45 |
| Respiratory Pathologies | ||
| No | 123 | 99.19 |
| Yes | 1 | 0.81 |
| Gastrointestinal Pathologies | ||
| No | 122 | 98.39 |
| Yes | 2 | 1.61 |
| Neurologic Pathologies | ||
| No | 117 | 94.35 |
| Yes | 7 | 5.65 |
| Metabolic Pathologies | ||
| No | 111 | 89.52 |
| Yes | 13 | 10.48 |
| Other Pathologies | ||
| No | 114 | 91.94 |
| Yes | 10 | 8.06 |
| Comorbidity | ||
| No pathologies | 81 | 65.32 |
| 1 pathology | 25 | 20.16 |
| 2 pathologies | 10 | 8.06 |
| 3 pathologies | 7 | 5.65 |
| 4 or more pathologies | 1 | 0.81 |
Test-retest reliability of PVS screening
| Time 1 | Time 2 | Spearman correlation | |
|---|---|---|---|
| PA | 135.31 (127.79) | 125.62 (108.15) | 0.38 ( |
| F&V | 3.21 (1.99) | 2.92 (1.88) | 0.59 ( |
| TB | 0.70 (0.45) | 0.68 (0.46) | 0.76 ( |
PVS-SQ Concurrent validity
| PA | F&V | TB | |||||||
|---|---|---|---|---|---|---|---|---|---|
| PVS-SQ | Accelerometer | r (n) | PVS-SQ | FFQ PREDIMED | rSpearman (n) | PVS-SQ | Co-oximeter | r(n) | |
| Sex | |||||||||
| Men | 137.15 (104.73) | 156.09 (160.62) | .30* ( | 2.39 (1.89) | 1.20 (1.21) | .27* ( | 0.63 (0.49) | 0.76 (0.43) | .64* ( |
| Women | 110.95 (110.62) | 127.35 (136.29) | .36* ( | 3.43 (1.74) | 1.63 (1.45) | .65* ( | 0.72 (0.45) | 0.81 (0.40) | .70* ( |
| HC | |||||||||
| A | 103.50 (107.07) | 145.53(135.71) | .14* ( | 2.55 (1.64) | 1.39 (1.29) | .49* ( | 0.52 (0.50) | 0.77 (0.42) | .57* ( |
| B | 152.38 (110.20) | 84.11 (98.14) | .39* ( | 3.07 (2.12) | 1.32 (1.38) | .48* ( | 0.78 (0.41) | 0.83 (0.38) | .86* ( |
| C | 116.50 (103.95) | 200.95 (182.29) | .63* ( | 3.15 (1.80) | 1.49 (1.49) | .70* ( | 0.71 (0.46) | 0.76 (0.43) | .74* ( |
| Total | 124.59 (108.32) | 141.50 (148.86) | .34* ( | 2.92 (1.88) | 1.40 (1.38) | .50* ( | 0.67 (0.47) | 0.79 (0.40) | .69* ( |
*P < 0.05
PVS-SQ Diagnostic Efficiency Index
| TP | FP | FN | TN | Se, % (95% CI) | Sp, % (95% CI) | Accuracy, % (95% CI) | LR+ (95% CI) | LR- (95% CI) | |
|---|---|---|---|---|---|---|---|---|---|
| PA | 74 | 21 | 15 | 5 | 81.3 (72.1–88.0) | 19.2 (8.5–37.8) | 67.5 (58.6–75.3) | 1.0 (0.8–1.3) | 0.88 (0.5–1.6) |
| F&V | 90 | 1 | 27 | 3 | 76.9 (68.5–83.6) | 75.0 (30.0–95.4) | 76.9 (68.6–83.53) | 3.1 (0.6–16.8) | 0.31 (0.2–0.4) |
| TB | 24 | 15 | 1 | 81 | 96.0 (80.5–99.3) | 84.4 (75.6–90.3) | 86.8 (79.6–91.7) | 6.1 (3.8–9.8) | 0.05 (0.0–0.3) |
TP true positive, F false positive, FN false negative, TN true negative, NE not estimable
Fig. 2PVS-SQ ROC curves
Fig. 3Feasibility and utility scores distribution